Zhou, C., Zhou, F., Wang, H., Zhuo, M., Yang, N., Li, J., Jin, S., Han, Z., Zeng, G., Liu, J., Song, Y., Liu, H., Wang, L., Li, L., Chen, J., Bai, J., Ran, F. (2025). A retrospective study of anlotinib plus third-generation EGFR-TKIs in advanced non-small cell lung cancer with gradual or oligo progression after EGFR-TKIs treatment (ALTER-L058).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8600